411 Novel intratumoral agent, INT230–6 induces cancer cell death, increases tumor infiltrates and results in durable benefit alone or in combination with pembrolizumab in refractor...

by Lilian Siu, Jacob Thomas, Diana Hanna, Anthony El-Khoueiry, Nilofer Azad, Lewis Bender, Ian Walters, Giles Whalen, Matthew Ingham
Published 2020-11-01

Combination checkpoint blockade for metastatic cutaneous malignancies in kidney transplant recipients

by Richard Carvajal, Yvonne Saenger, Matthew Ingham, Shaheer Khan, Diana McDonnell, Shana M Coley, Geoffrey Dube, Faramarz H Samie, Larisa J Geskin, Daniel Brouder
Published 2020-06-01

Unmet Medical Needs and Future Perspectives for Leiomyosarcoma Patients—A Position Paper from the National LeioMyoSarcoma Foundation (NLMSF) and Sarcoma Patients EuroNet (SPAEN)

by Bernd Kasper, Annie Achee, Kathrin Schuster, Roger Wilson, Gerard van Oortmerssen, Rebecca A Gladdy, Matthew L Hemming, Paul Huang, Matthew Ingham, Robin L Jones, Seth M Pollack, Denise Reinke, Roberta Sanfilippo, Scott M Schuetze, Neeta Somaiah, Brian A Van Tine, Breelyn Wilky, Scott Okuno, Jonathan Trent
Published 2021-02-01